title: Endothelial cells modulate smooth muscle cell morphology by inhibition of transforming growth factor-beta 1 activation.
abstract: BACKGROUND
  We have previously demonstrated in a coculture model that endothelial cells (ECs) exert regulatory control over smooth muscle cell (SMC) morphology. This study was performed to test the hypothesis that ECs inhibit transforming growth factor-beta 2 (TGF-beta 1) activation through the release of plasminogen activator inhibitor (PAI-1).
  
  
  METHODS
  Bovine SMCs were cultured on a thin, semipermeable membrane, either alone or opposite ECs in coculture (SMC/EC). Conditioned media and cell lysates at 1, 5, and 21 days were assayed for TGF-beta 1 and PAI-1 by enzyme-linked immunoabsorbent assay. Cell proliferation rates, protein, and DNA content were measured and compared with SMC morphology.
  
  
  RESULTS
  Activation of TGF-beta 1 was significantly decreased (1.2% versus 18.9% active TGF-beta 1 p < 0.05) and PAI-1 was increased (659 pg/ml versus 343 pg/ml p < 0.05) in SMC/EC medium on day 1, compared with the medium of SMC alone. Significantly higher levels of PAI-1 were measured in cell lysates of cocultured ECs (128 pg/micrograms DNA) than in cocultured SMCs (5.8 pg/micrograms DNA, p < 0.05). SMC/EC coculture prevented the SMC hill-and-valley growth morphology seen in SMCs cultured alone.
  
  
  CONCLUSIONS
  In a model designed to study SMC/EC interactions, it was seen that ECs can alter growth characteristics of SMCs by producing PAI-1, which interferes with the plasminogen pathway of TGF-beta 1 activation. This suggests that reduced EC PAI-1 production could play a role in alteration of SMC phenotype in vivo.
authors: Section of Vascular Surgery, Dartmouth-Hitchcock Medical Center, Lebanon, N.H. 03756, USA.
authors: G B
authors: GB
authors: Nackman
authors: F R
authors: FR
authors: Bech
authors: M F
authors: MF
authors: Fillinger
authors: R J
authors: RJ
authors: Wagner
authors: J L
authors: JL
authors: Cronenwett
mesh_terms: D000818:Animals; D001011:Aorta / Q000166:cytology; D002417:Cattle; D002455:Cell Division / Q000187:drug effects; D048429:Cell Size / Q000502:physiology; D002478:Cells, Cultured / Q000502:physiology; D004247:DNA / Q000032:analysis; D004730:Endothelium, Vascular / Q000166:cytology / Q000502:physiology*; D009131:Muscle, Smooth, Vascular / Q000166:cytology / Q000502:physiology*; D017395:Plasminogen Activator Inhibitor 1 / Q000378:metabolism; D011506:Proteins / Q000032:analysis; D015842:Serine Proteinase Inhibitors / Q000378:metabolism; D013936:Thymidine / Q000378:metabolism; D016212:Transforming Growth Factor beta / Q000037:antagonists & inhibitors* / Q000378:metabolism; D014316:Tritium / Q000378:metabolism
chemical_list: D017395:Plasminogen Activator Inhibitor 1; D011506:Proteins; D015842:Serine Proteinase Inhibitors; D016212:Transforming Growth Factor beta; D014316:Tritium; D004247:DNA; D013936:Thymidine